Variables

AOR

95% CI

p-value

Treatments

Albendazole

Reference

Mebendazole

2.6

[1.2%; 6.1%]

0.029*

Period (3 years)

2017

Reference

2018

0.20

[0.1%; 5.1%]

0.003*

2019

0.08

[0%; 2.1%]

0.000**